About Virtue Diagnostics
Virtue Diagnostics is a company based in Suzhou (China) founded in 2019.. Virtue Diagnostics has raised $130 million across 2 funding rounds from investors including Sequoia Capital, Morningside and Yuanhe Holdings. Virtue Diagnostics has completed 1 acquisition, including Labtest. Virtue Diagnostics operates in a competitive market with competitors including Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
- Headquarter Suzhou, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$130 M (USD)
in 2 rounds
-
Latest Funding Round
$100 M (USD), Series B
Jan 06, 2022
-
Investors
Sequoia Capital
& 3 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Virtue Diagnostics
Virtue Diagnostics has successfully raised a total of $130M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $100 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $100.0M
-
First Round
First Round
(21 Dec 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series B - Virtue Diagnostics | Valuation | Sequoia Capital China , Morningside | |
| Dec, 2020 | Amount | Series A - Virtue Diagnostics | Valuation | Lilly Asia Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Virtue Diagnostics
Virtue Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Sequoia Capital, Morningside and Yuanhe Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on early-stage investments
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Virtue Diagnostics
Virtue Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Labtest. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Scientific consulting, technical assistance, and laboratory services are offered.
|
1971 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Virtue Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Virtue Diagnostics Comparisons
Competitors of Virtue Diagnostics
Virtue Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of immunoassays for diagnostic purposes
|
|
| domain | founded_year | HQ Location |
Provider of products and services for human protein biomarker research and development
|
|
| domain | founded_year | HQ Location |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| domain | founded_year | HQ Location |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| domain | founded_year | HQ Location |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Virtue Diagnostics
When was Virtue Diagnostics founded?
Virtue Diagnostics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Virtue Diagnostics located?
Virtue Diagnostics is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Who is the current CEO of Virtue Diagnostics?
Johnson Zhang is the current CEO of Virtue Diagnostics.
Is Virtue Diagnostics a funded company?
Virtue Diagnostics is a funded company, having raised a total of $130M across 2 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Dec 21, 2020.
What does Virtue Diagnostics do?
Virtue Diagnostics was founded in 2019 in Suzhou, China, within the biotechnology sector. An in vitro assay platform is developed and supplied for diagnostic applications. The technology is applied in early screening, diagnosis, treatment monitoring, and minimal residual disease management. It addresses infectious diseases, cancer, maternal and fetal health, and chronic conditions, supporting healthcare operations across these areas.
Who are the top competitors of Virtue Diagnostics?
Virtue Diagnostics's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
How many acquisitions has Virtue Diagnostics made?
Virtue Diagnostics has made 1 acquisition, including Labtest.
Who are Virtue Diagnostics's investors?
Virtue Diagnostics has 4 investors. Key investors include Sequoia Capital, Morningside, Yuanhe Holdings, and Lilly Asia Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.